<DOC>
	<DOCNO>NCT02830217</DOCNO>
	<brief_summary>ST-elevation myocardial infarction ( STEMI ) urgent symptom associate sudden myocardial ischemia ST segment elevate ECG . Primary percutaneous coronary intervention ( PCI ) re-open infarct artery efficiently STEMI patient . However , patient readmitted shortly primary PCI several unfavorable clinical outcome include thrombosis stent , recurrence myocardial infarction , stroke , heart failure . This study intend test predictive ability new biomarker soluble ST2 ( sST2 ) peripheral blood . Previous study show elevated sST2 highly associate unfavorable clinical outcome patient ischemia heart diseases heart failure . This study investigate ability sST2 predict unfavorable outcome STEMI patient primary PCI .</brief_summary>
	<brief_title>Evaluation Soluble ST2 Patients Receiving Primary PCI With ST-elevation Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Patients first onset STEMI receive primary PCI accord 2013 ACCF/AHA guideline management STEMI Patients previous stroke , pneumonia , cirrhosis , autoimmune disease severe infection exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>STEMI</keyword>
	<keyword>primary PCI</keyword>
	<keyword>sST2</keyword>
	<keyword>prognosis</keyword>
</DOC>